Increasing numbers of genetic origins are being reported for congenital muscle fiber-type disproportion. Most of these identified disorders are genetic myopathies. This is the first case report (to our knowledge) demonstrating congenital central hypoventilation syndrome due to PHOX2B mutations with congenital muscle fiber-type disproportion. The muscle histopathologic findings in the patient showed no changes of disuse atrophy and suggest that PHOX2B mutations may have an additional role in muscle development, contributing to respiratory failure in congenital central hypoventilation syndrome.
Clarke NF, North KNCongenital fiber type disproportion: 30 years on. J Neuropathol Exp Neurol. 2003;62(10):977-989.
2.
Iannaccone ST , Bove KE, Vogler CA, Buchino JJType 1 fiber size disproportion: morphometric data from 37 children with myopathic, neuropathic, or idiopathic hypotonia . Pediatr Pathol. 1987; 7(4):395-419.
3.
Imoto C., Nonaka I.The significance of type 1 fiber atrophy (hypotrophy) in childhood neuromuscular disorders. Brain Dev. 2001;23(5):298-302.
4.
Sarnat HBCerebral dysgeneses and their influence on fetal muscle development. Brain Dev. 1986;8(5):495-499.
5.
Jaffe M., Shapira J., Borochowitz Z.Familial congenital fiber type disproportion (CFTD) with an autosomal recessive inheritance. Clin Genet. 1988;33(1):33-37.
6.
Kim WK, Choi BO, Cheon HY, et al. Muscle fiber type disproportion with an autosomal dominant inheritance . Yonsei Med J. 2000;41(2):281-284.
7.
Okamoto N., Toribe Y., Nakajima T., et al. A girl with 1p36 deletion syndrome and congenital fiber type disproportion myopathy. J Hum Genet. 2002;47(10):556-559.
8.
Matera I., Bachetti T., Puppo F., et al. PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset central hypoventilation syndrome. J Med Genet . 2004;41(5):373-380.
9.
Amiel J., Laudier B., Attie-Bitach T., et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet. 2003;33(4):459-461.
10.
Bachetti T. , Matera I., Borghini S., et al. Distinct pathogenetic mechanisms for PHOX2B associated polyalanine expansions and frameshift mutations in congenital central hypoventilation syndrome. Hum Mol Genet. 2005;14(13):1815-1824.
11.
Trochet D., Hong SJ, Lim JK, et al. Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction. Hum Mol Genet. 2005; 14(23):3697-3708.
12.
Weese-Mayer DE, Berry-Kravis EM, Zhou L., et al. Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b. Am J Med Genet. 2003;123(3):267-278.
13.
Borghini S. , Bachetti T., Fava M., et al. The TLX2 homeobox gene is a transcriptional target of PHOX2B in neural-crest-derived cells. Biochem J . 2006;395(2):355-361.
14.
Dauger S., Pattyn A., Lofaso F., et al. Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways. Development. 2003;130(26):6635-6642.
15.
Pattyn A., Goridis C., Brunet JFSpecification of the central noradrenergic phenotype by the homeobox gene Phox2b. Mol Cell Neurosci. 2000;15(3):235-243.
16.
Stornetta RL , Moreira TS, Takakura AC, et al. Expression of Phox2b by brainstem neurons involved in chemosensory integration in the adult rat. J Neurosci. 2006;26(40):10305-10314.
17.
Jiang Y., Matsuo T., Fujiwara H., et al. ARIX and PHOX2B polymorphisms in patients with congenital superior oblique muscle palsy. Acta Med Okayama. 2005 ;59(2):55-62.
